Intracranial pressure monitoring is considered the standard of care for severe traumatic brain injury and is used frequently.However, the effi cacy of treatment based on monitoring in improving the outcome has not been rigorously assessed.
We conducted a trial in which we included 26 patients of all types of traumatic brain injury (TBI) and they were monitored for intracranial pressure by Conventional fl uid fi lled systemwith a manometer (Group1) and compared with the Fibreoptictransducer-tipped intracranial pressure monitoring system(Group 2).The main aim of this study was to examine the relationship between Intracranial Pressure (ICP) monitoring and in-hospital mortality.
The median length of stay in the ICU was similar in the two groups (12 days in the conventional pressure-monitoring group and 9 days in the new fi breoptic group; P=0.25), the number of days of brain-specifi c treatments (e.g., administration of hyperosmolar fl uids and the use of hyperventilation) in the ICU was similar in both groups. The distribution of serious adverse events was similar in the two groups.
We concluded that ICP monitoring (as is any monitoring modality) is a useful guide for management. The outcomes are decided by the differences in management protocols that the knowledge of the said parameter brings about. ICP monitoring is recommended for the better management of traumatic brain injury and fi breoptic ICP monitoring seems to be benefi cial than using the conventional methods of ICP monitoring with manometer.
Key words: Brain Trauma foundation, Camino, Fibreoptic intracranial monitor, ICP, TBI, Nepal perfusion to meet the brain's metabolic demands for oxygen and glucose. Because the brain is encased by the nonexpendable skull, an increase in intracranial pressure (ICP) may impede cerebral blood fl ow (CBF) and lead to cerebral ischemia. Increased ICP is an important cause of secondary brain injury, and its degree and duration is associated with outcome after TBI. 16, 15 ICP monitoring is the most widely used intracranial monitor because prevention and control of increased ICP and maintenance of cerebral perfusion pressure (CPP) are fundamental therapeutic goals after TBI. Traumatic brain injury (TBI) remains a major cause of deathand disability worldwide. In the United States alone, morethan 53,000 individuals die annually because of TBI, contributingto 30.5% of all injury-related deaths. In 2010, the estimated burdenof TBI on the U.S. economy was approximately $76.5 billion.After the initial injury, mass lesions, an increase in brain-water content (edema), and an increase in blood volume, can result inrising pressure in the rigid skull, which may lead to brain tissueherniation, impaired cerebral perfusion, and, without intervention, further damage to the brain. Among those who die from TBI, themajority die because of uncontrolled rise of intracranial pressure(ICP), mostly within the fi rst 48 hours of injury. After a severe TBI, efforts are focused on prevention of further damage through intensive monitoring and prompt intervention. 11 In 1951, Guillaume and Janny fi rst described continuous ICP monitoring using an electronic magnetic transducer to measure changes in ventricular fl uid pressure. Since then, invasive ICP monitoring has become an increasingly employed tool to care for patients with severe TBI and has been adopted as part of the Brain Trauma Foundation (BTF) guidelines for the management of severe TBI, based on indirect evidence in which observational studies linked increasedICP with worse outcomes.
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Materials and Methods:
This is a prospective study. Weconducted the study of fi rst series of patients during 2011-2016in which we included 26 patients of all types of traumatic brain injury and they were monitored for intracranial pressure by the conventional method of ICP monitoring with the fl uid fi lled catheter system with manometer (Group 1).For this, we followed the existing protocol of ICP monitoring of the Department of Neurosurgery of Bir Hospital (Figure1). The catheters were placed either intraventricular or in the subdural space and the catheter was connected to a manometer (external transducer). In this group, ICP monitoring was also done in all types of traumatic 3 -fi rstly, all salvageable patients with a TBI (GCS 3-8 after resuscitation) and an abnormal CT scan. (An abnormal CT scan of the head is one that reveals hematomas, contusions, swelling, herniation, or compressed basal cisterns). Secondly, allthe patients with severe TBI with a normal CT scan if two or more of the following features are noted at admission: age over 40 years, unilateral or bilateral motor posturing, or systolic blood pressure (BP)<90 mm Hg. The Camino fi breoptic monitoring kit contains a sterile transducer-tipped pressure monitoring catheter and its method of measuring pressure is unique.
This was an observational cohort study, with the exposure of interest being invasive ICP monitoring in patients with severe TBI. The main aim of this study was to examine the relationship between ICP monitoring and in-hospital mortality.
We used two analytic approaches to assess this relationship. First, we used ICP monitoring as a patientlevel variable to determine the association between ICP monitoring and mortality. Previously, we were using the conventional method of fl uid fi lled catheter system for the ICP monitoring.Secondly, after the availability of the Caminofi breoptic ICP monitoring system in National Trauma Centre, we started to use it solely as it has ease of insertion, can be inserted in severely compromised ventricles or those with midline shift, has low risk of hemorrhage and infection and has zero drift. The subdural fi breoptic catheters were used in those patients who underwent either craniotomy ordecompressivecraniectomy. The parenchymal catheters were used mainly in those patients with diffuse brain injuries or who did not need craniotomy or craniectomy as the initial part of treatment. The intraventricular catheters were used in those patients who had normal sized ventricles. We compared this method with the conventional methodof ICP monitoring; however, we only recruited the severe TBI patients in Group 2.
We used data derived from the medical record departments of Bir Hospital and National Trauma Centre,both hospitals belonging to the National Academy of Medical Sciences (NAMS). All detailed history and the physical examination were recorded and all the required data were taken for the study.The primary endpoint for this study was the odds of in-hospital death after TBI.
Statistical analysis
The primary hypothesis was tested with the use of the blocked Wilcoxon test, with blocking on stratifi cation factors, and a two-sided signifi cance level of 0.05. We obtained odds ratios and confi dence intervals from a logistic proportional-odds model, accounting for the same factors. This analysis was supplemented by similar analyses of individual measures and composite analyses of subgroup measures. Cox models were used to analyze survival. A signifi cance level of 0.01 was used to test secondary hypotheses. The main analyses included data on all participants randomly assigned to a treatment group (intention-to-treat population). Sensitivity analyses included analyses restricted to patients who survived.
We calculated standardized differences to compare baseline characteristics between those who underwent ICP monitoring by conventional method and the new method of fi breoptic ICP monitoring. 
Results:
The mean age of presentation for the patients who underwent ICP Monitoring by using the conventional methodwas 52 years. There were total of 26 patients who were included in the study for the ICP monitoring by the conventional method. The maximum patients were in age group of 40 to 60 years which were 13. The mode of injury was fall in maximum number of patients (11) followed by seven patients of Road traffi c accident.Almost half of the patients (48%) had mild head injury followed by moderate head injury (43%) and severe head injury (9%) respectively (Figure 3) . After monitoring the ICP of these patients good recovery was seen in 8 patients and we had 8 mortality in the series of 26 patients whom we used the conventional method as the ICP monitoring tool. ICP monitoring was also helpful in non-severe traumatic brain injury case, too from old cohort (Group 1) as one of the cases had to undergo evacuation of hematoma as the ICP started to rise and subsequent CT scan of the patient showed expanding hematoma.
We have now started using the Camino fi breoptic monitoring system for the ICP monitoring and have included 15 patients in the series (Group 2). The mean age of presentation for the patients who underwent ICP Monitoring by using Fibreoptictransducers was 48 years. The maximumnumbers of patients were in age groups of 20 to 40 years and there were fi ve patients of the age more than 60 years. There were eight patients of fall followed by three patients of Road traffi c accident. We placed the catheter in subdural space in nine patients andintraventricular in two patientsandparenchymal in four patients (Figure 4) . Reason of using suduralcatheters in majority of cases is for its ease of placementduring the craniotomy or craniectomy who needed it and its inherent less complications. We have included only the severe TBI patients in the Fibreoptic monitoring series.After monitoring the ICP of the all the 15patients of severe TBIin this series (Group 2), good recovery was seen inseven patients and we hadtwo deaths.
There were signifi cant differences between the conventional method of Intracranial Pressure Monitoring and the new fi breoptic method. The good recovery was seen in almost half of the patients with new fi breoptic method of Intracranialpressure monitoring compared to the conventional method. The median length of stay in the Intensive Care Unit (ICU) was similar in the two groups (12 days in the conventional pressure-monitoring group and 9 days in the new fi breopticgroup; P=0.25) ( Figure  5 ), the number of days of brain-specifi c treatments (e.g., administration of hyperosmolar fl uids and the use of hyperventilation) in the ICU was similar in both groups. The distribution of serious adverse events was similar in the two groups.There was signifi cant reduction in the mortality in the Group-2 patients (eight mortality out of 26 patientsin the conventionalmethod and only two mortality in the new fi breoptic method; p=<0.01) (Figure 6 ). The reason can be due to the good neurocriticaland nursing care by health personnel in National Trauma Centre.The old cohort (Group 1) had high chances of malposition, occlusion, infection and hemorrhage compared to the new cohort (Group 2) ofFibreoptic ICP monitoring.
Discussion
In the fi eld of neurotrauma and critical care, invasive ICP monitoring has long been considered a standard of care for severe TBI patients without being supported by rigorous assessment of its effectiveness in improving outcomes. Normal and pathologic ICP: Normal ICP varies with age, body position, and clinical condition. 1 The normal ICP is 7-15 mm Hg in a supine adult, 3-7 mm Hg in children, and 1.5-6 mm Hg in term infants. The defi nition of intracranial hypertension depends on the specifi c pathology and age, although ICP >15 mm Hg is generally considered to be abnormal. 
Figure 6: Comparing outcome of patients in the conventional method (Group 1) with Fibreoptic method (Group 2).
In the injured brain, there may be intra parenchymal pressure gradients between the supra and infra-tentorial compartments and bilateral monitoring has revealed differential pressures across the midline in the presence of hematomas and also in the absence of space-occupying lesions.
17 Increased ICP causes a critical reduction in CPP and CBF and may lead to secondary ischemic cerebral injury. 28, 21 A number of studies have shown that high ICP is strongly associated with poor outcome, particularly if the period of intracranial hypertension is prolonged. Increased ICP can also cause actual shift of brain substance resulting in structural damage to the brain and to herniation through the tentorial hiatus or foramen magnum. The latter results in pressure on the brainstem causing bradycardia and hypertension (the classic Cushing refl ex) and, if untreated, respiratory depression and death.
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General indications for ICP monitoring:
Despite the widespread applications of ICP monitoring, there are no data from randomized controlled trials that can clarify its role in acute coma. 27 With the exception of monitoring after severe TBI, the indications for ICP monitoring are not well established and vary from center to center. Case-mix adjusted mortality in comatose patients with intracranial hemorrhage is lower in those who receive ICP monitoring compared with those who do not and increased ICP is associated with poor prognosis after subarachnoid hemorrhage. 13 There is little evidence to support ICP monitoring in other neurological conditions, such as acute stroke, when there is no benefi t over clinical monitoring alone. ICP monitoring after anoxic injury after cardiac arrest has little value in targeting treatment, although it may be useful in hepatic encephalopathy.
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ICP monitoring after TBI:
In 1982, Narayan et al. demonstrated in a prospective study of 133 patients that outcome prediction after TBI was increased when ICP monitoring was added to standard clinical observations. Subsequently, analysis of the National Traumatic Coma Data Bank showed that the proportion of hourly ICP recordings more than 20 mm Hg was the next most signifi cant predictor of poor outcome after the usual clinical descriptors of age, admission motor score, and abnormal pupil responses. Despite the absence of Class 1 evidence demonstrating the benefi t of ICP monitoring on outcome after TBI, there is a large body of clinical evidence supporting its use to guide therapeutic interventions, detect intracranial mass lesions early, and assess prognosis. ICP monitoring is recommended by consensus guidelines for head injury management and is accepted as a relatively low-risk, high-yield and value for money intervention. 15, 16 The Brain Trauma Foundation recommends ICP monitoring in all patients with a severe TBI (Glasgow Coma Score 3-8) and either an abnormal CT scan or a normal scan and the presence of two or more of thefollowing three risk factors at admission: age >40 years; unilateral or bilateral motor posturing; a systolic a BP <90 mm Hg. There is around 60% chance of increased ICP in these patients. Much information is available from ICP monitoring in addition to the measurement and display of absolute ICP. CPP is easily calculated as the difference between mean ABP (MAP) and ICP (CPP =MAP -ICP) and is a measure of the pressure gradient across the cerebral vascular bed. Pathologic ICP wave forms can be identifi ed and analyzed. 17 ICP monitoring can also be augmented by measurement of indices describing cerebrovascular pressure reactivity (CVR) and pressure-volume compensatory reserve.
In the Rescue ICP Trial, the third tier of treatment consisted of decompressivecraniectomy for refractory intracranial hypertension in TBI. There have been limited studies in TBI from Nepal where ICP monitoring has been studied, whereas other studies e.g. Roka et al, in their article of Non decompressive single stage bilateral craniotomy in TBI, pointed out as one of the limitations of their study to be unavailability of ICP monitoring in their patients. 28 In our study, we demonstrated a strong association between ICP monitoring and a lower risk of death after severe TBI. This fi nding was consistent when we examined the effectiveness of this technology at either the patient or hospital level. 18 Further, there appeared to be a doseresponse, with higher rates of ICP monitoring associated with lower rates of mortality, lending further credence to a causal relationship. Accurate, continuous ICP monitoring by an invasive tool can lead to the prompt recognition of spiking pressure around the injured parts of the brain. Such recognition could potentially lead to timely intervention that is able to control the rising pressure inside the rigid skull, a process that is thought to be the leading cause of death among severe TBI victims, especially during the fi rst 48 hours after injury. 5, 6, 14 Despite the plausibility of its effi cacy in guiding us to provide better care, many have questioned its effectiveness based on several studies that failed to provide conclusive, consistent results. This inconsistency among previous studies might explain the wide variability in ICP monitoring utilization across different hospitals. Our fi ndings agree with a number of previous studies that support the value of ICP monitoring in TBI, but contrast with several other studies that either failed to show an association between ICP monitoring and better outcomes, or showed an association between ICP monitoring and higher mortality. 20, 26 Theonly randomized trial in this area showed no difference in the primaryoutcome, a compositemeasure based on performance across 21measures of functional and cognitive status, between care focused onmaintaining ICP at 20 mmHg or less and care based on imaging andclinical examination in the setting of the developing world, whereICP monitoring is very rarely used. However, the trial was notsuffi ciently powered to detect a mortality difference between bothgroups. In addition, differences in injury characteristics, prehospital,intensive care unit (ICU) and post-ICU structure and processesof care, and the observation of ''delayed mortality'' due tomedical complications, accounting for more than one third of deathssubsequent to TBI in Latin America, may render as questionable anyextrapolation of epidemiologic or treatment studies from the developingto developed world. 6, 8, 23 Several single-center and multicenter observational studies have shown that ICP-targeted management of TBI is associated with worse outcomes, including prolonged mechanical ventilation, worse functional status, and higher risk of pneumonia, acute kidney injury, and mortality. However, the results of these studies may be biased because they were retrospective and sicker patients may be more likely to receive ICP monitoring. Chesnut and colleagues conducted a prospective randomized clinical trial to determine whether ICP monitoring improves outcomes. Since invasive ICP monitoring is considered standard of care, this study would have lacked clinical equipoise if conducted in the United States. Therefore, this study had to be conducted in centers that deviated from this 'standard'. The authors recruited patients from Bolivia and Ecuador, where ICP monitoring was not the standard of care. The authors concluded that ICP guided care was not superior to care based on imagingand clinical exam alone, contrary to published guidelines. 9, 12, 24 The Camino fi breoptic ICP monitoring system eliminates the problems inherent in the conventional fl uid-fi lled system of ICP monitoring. For example, it gives a precise pressure measurement and artifact free high fi delity waveforms. Moreover, it has zero drift. So, a single zero-calibration is enough for the whole period of ICP monitoring. In contrast, conventional system has to be zero calibrated every four hours. So, it is alabour intensive and has high chances of occlusion, malposition and infection.The limiting factor for the use of the Camino fi breoptic kit is its high cost. It is about fi ve times costlier than the conventional system of ICP monitoring.
In our study, we found considerable unexplained variation inhospital mortality, even after accounting for measured patient-andhospital-level characteristics. Moreover, our data were derived from National trauma centers that have interest in high-quality careby virtue of their participation and quality improvementactivities. For that reason, study may have lower mortalityrates.
Limitations Of The Study:
This study is a single institutional study though two hospitals and therefore may not be fully generalized. Group 1 had all types of traumatic brain injuries while group 2 had only severe traumatic brain injuries. Therefore, the comparison cohort group may not be too ideal. Moreover, our sample size was small in both groups. We could not include all the patients in Group 1 who were eligible for ICP monitoring according to the Departmental Protocol for ICP measurement. Similar was the case for Group 2 patients and one of the factors was the high cost of the Fibreoptic catheters and there were various other factors, too for both the Groups. Therefore, potential introduction of errors due to small sample size cannot be ruled out.
Conclusions:
We concluded that ICP monitoring (as is any monitoring modality) is a useful guide for management. The outcomes are decided by the differences in management protocols that the knowledge of the said parameter brings about. ICP monitoring is recommended for the better management of traumatic brain injury injury and fi breoptic ICP monitoring seems to be benefi cial than using the conventional method of ICP monitoring with manometer.
